Pregled bibliografske jedinice broj: 784284
GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases
GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases // Current Pharmaceutical Design, 21 (2015), 34; 4937-4938 doi:10.2174/1381612821999150918145111 (podatak o recenziji nije dostupan, uvodnik, znanstveni)
CROSBI ID: 784284 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases
Autori
Vlainić, Josipa
Izvornik
Current Pharmaceutical Design (1381-6128) 21
(2015), 34;
4937-4938
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, uvodnik, znanstveni
Ključne riječi
GABA; GABAergic system; therapy
Sažetak
In the thematic issue edited the prominent authors bring novel knowledge on GABAergic system functions and give the overview of several GABA-related therapeutic options with intention to discuss evidence on the therapeutic potential and the rationale of novel GABAergic treatment of several disorders only recently connected, among others, to the abnormal function of GABAergic neurotransmission. Namely, the early clinical studies or pre-clinical evidences suggest that a promising GABAergic strategy could be developed since GABA targeting could reduce the symptoms associated with several diseases whose symptoms were recently attributed to the imbalanced inhibitory/excitatory GABA signal.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi fulir.irb.hr www.eurekaselect.comCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
